BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28465362)

  • 1. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.
    Bhattacharya S; Muhammad N; Steele R; Kornbluth J; Ray RB
    Cancer Prev Res (Phila); 2017 Jun; 10(6):337-344. PubMed ID: 28465362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
    Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
    Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
    Bose A; Baral R
    Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
    Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
    Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling.
    Rajamoorthi A; Shrivastava S; Steele R; Nerurkar P; Gonzalez JG; Crawford S; Varvares M; Ray RB
    PLoS One; 2013; 8(10):e78006. PubMed ID: 24147107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
    J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
    Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
    Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines.
    Kim MJ; Lee JC; Lee JJ; Kim S; Lee SG; Park SW; Sung MW; Heo DS
    Tumour Biol; 2008; 29(1):28-34. PubMed ID: 18497546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.
    Schilling B; Halstead ES; Schuler P; Harasymczuk M; Egan JE; Whiteside TL
    Cancer Immunol Immunother; 2012 Sep; 61(9):1395-405. PubMed ID: 22270713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients.
    Trivedi S; Srivastava RM; Concha-Benavente F; Ferrone S; Garcia-Bates TM; Li J; Ferris RL
    Clin Cancer Res; 2016 Nov; 22(21):5229-5237. PubMed ID: 27217441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
    Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
    Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the change in cetuximab-induced antibody-dependent cellular cytotoxicity activity of natural killer cells by steroid.
    Kumai T; Oikawa K; Aoki N; Kimura S; Harabuchi Y; Kobayashi H
    Head Neck; 2016 Mar; 38(3):410-6. PubMed ID: 25352398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.
    Srivastava RM; Trivedi S; Concha-Benavente F; Gibson SP; Reeder C; Ferrone S; Ferris RL
    Clin Cancer Res; 2017 Feb; 23(3):707-716. PubMed ID: 27496866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.
    Pinette A; McMichael E; Courtney NB; Duggan M; Benner BN; Choueiry F; Yu L; Abood D; Mace TA; Carson WE
    Cancer Immunol Immunother; 2019 Aug; 68(8):1379-1389. PubMed ID: 31338557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
    Brennan VC; Wang CM; Yang WH
    J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
    Crist M; Yaniv B; Palackdharry S; Lehn MA; Medvedovic M; Stone T; Gulati S; Karivedu V; Borchers M; Fuhrman B; Crago A; Curry J; Martinez-Outschoorn U; Takiar V; Wise-Draper TM
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36328378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.
    Kundu K; Ghosh S; Sarkar R; Edri A; Brusilovsky M; Gershoni-Yahalom O; Yossef R; Shemesh A; Soria JC; Lazar V; Joshua BZ; Campbell KS; Elkabets M; Porgador A
    Cancer Immunol Res; 2019 Jul; 7(7):1120-1134. PubMed ID: 31164357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.
    Jie HB; Schuler PJ; Lee SC; Srivastava RM; Argiris A; Ferrone S; Whiteside TL; Ferris RL
    Cancer Res; 2015 Jun; 75(11):2200-10. PubMed ID: 25832655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.